Dakota Wealth Management’s GSK GSK Stock Holding History

Dakota Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Buy	4,219 +190	+5%	+$10K	﹤0.01%	736
2026 Q1	$222K	Sell	4,029 -321	-7%	-$17.4K	﹤0.01%	721
2025 Q4	$213K	Buy	+4,350	New	+$203K	﹤0.01%	728
2025 Q3	–	Sell	-5,428	Closed	-$208K	–	713
2025 Q2	$208K	Buy	+5,428	New	+$207K	﹤0.01%	721
2023 Q2	–	Sell	-7,838	Closed	-$279K	–	658
2023 Q1	$279K	Sell	7,838 -4,280	-35%	-$150K	0.02%	480
2022 Q4	$426K	Sell	12,118 -612	-5%	-$20.4K	0.03%	384
2022 Q3	$375K	Buy	+12,730	New	+$482K	0.03%	388

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dakota Wealth Management's GSK Position: Q2 2026 in Review

Dakota Wealth Management increased its GSK (GSK) stake by 4.7% in Q2 2026, buying an estimated $10K and bringing the position to 4,219 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #736.

Dakota Wealth Management first reported a position in GSK in Q3 2022 and has held it in 7 quarters since. The position peaked at $426K in Q4 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Dakota Wealth Management held 4,219 shares of GSK worth $221K as of Q2 2026.
Dakota Wealth Management bought 190 GSK shares in Q2 2026, an estimated $10K.
GSK made up ﹤0.01% of Dakota Wealth Management's portfolio in Q2 2026, its #736 holding.
Dakota Wealth Management first reported a position in GSK in Q3 2022 and has held it in 7 quarters since.
Dakota Wealth Management's GSK position peaked at $426K in Q4 2022.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.